Kolexia
Knebelmann Bertrand
Néphrologie
Hôpital Necker Enfants Malades
Paris, France
211 Activités
543 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Maladies du rein Polykystoses rénales Polykystose rénale autosomique dominante Néphropathie familiale avec surdité Insuffisance rénale Défaillance rénale chronique Cystinurie Insuffisance rénale chronique Protéinurie

Industries

Sanofi
15 collaboration(s)
Dernière en 2023
TRAVERE THERAPEUTICS, INC.
14 collaboration(s)
Dernière en 2023
Vertex
7 collaboration(s)
Dernière en 2023
Otsuka
5 collaboration(s)
Dernière en 2020

Dernières activités

HYDROchlorothiazide versus placebo to PROTECT polycystic kidney disease patients and improve their quality of life: study protocol and rationale for the HYDRO-PROTECT randomized controlled trial.
Trials   14 février 2024
Performance and clinical utility of a new supervised machine-learning pipeline in detecting rare ciliopathy patients based on deep phenotyping from electronic health records and semantic similarity.
Orphanet journal of rare diseases   10 février 2024
CARDINAL: A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Essai Clinique (Biogen)   01 février 2024
P168: MUC1 gene coding-VNTR alignment-free genotyping approach augmented ADTKD diagnosis in a cohort of 3735 patients with hereditary kidney diseases
2024 ACMG Annual Clinical Genetics Meeting   01 janvier 2024
Precision medicine and hierarchy of diagnostics and treatment in haematuria/proteinuria
Youtube @ ERA - European Renal Association   18 octobre 2023
FLUCOLITH: Multicenter, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Fluconazole in Hypercalcicuric Patients With Increased 1.25(OH) 2D Levels
Essai Clinique (Hospices Civils de Lyon)   31 août 2023
Validating a core outcome measure for pain in patients with autosomal dominant polycystic kidney disease
58th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology (ANZSN) 4–6 September 2023   27 août 2023
VNtyper enables accurate alignment-free genotyping of coding VNTR using short-read sequencing data in autosomal dominant tubulointerstitial kidney disease.
iScience   17 juin 2023
Phase 2a Study of VX-147 in Adults With APOL1-mediated Focal Segmental Glomerulosclerosis: A Phase 2a, Open-label, Single-arm, 2-Part Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of VX-147 in Adults With APOL1-mediated Focal Segmental Glomerulosclerosis
Essai Clinique (Vertex)   17 juin 2023
#6649 SIGNIFICANT CLINICAL IMPROVEMENT OF PAEDIATRIC AND ADULT PATIENTS WITH DISTAL RENAL TUBULAR ACIDOSIS AFTER 6 YEARS OF TREATMENT WITH SIBNAYAL®
60th ERA Congress, 15-18 June 2023: Congress Abstracts   14 juin 2023